PLURISTEM THERAPEUTICS INC - FORM 10-K - EX-23.1 - EXHIBIT 23.1 - September 11, 2014

Attached files

file filename
EX-10.19 - EXHIBIT 10.19 - PLURISTEM THERAPEUTICS INCexhibit_10-19.htm
EX-10.29 - EXHIBIT 10.29 - PLURISTEM THERAPEUTICS INCexhibit_10-29.htm
EX-10.27 - EXHIBIT 10.27 - PLURISTEM THERAPEUTICS INCexhibit_10-27.htm
EX-10.25 - EXHIBIT 10.25 - PLURISTEM THERAPEUTICS INCexhibit_10-25.htm
EX-10.26 - EXHIBIT 10.26 - PLURISTEM THERAPEUTICS INCexhibit_10-26.htm
EX-10.16 - EXHIBIT 10.16 - PLURISTEM THERAPEUTICS INCexhibit_10-16.htm
EX-10.23 - EXHIBIT 10.23 - PLURISTEM THERAPEUTICS INCexhibit_10-23.htm
EX-31.1 - EXHIBIT 31.1 - PLURISTEM THERAPEUTICS INCexhibit_31-1.htm
EX-10.28 - EXHIBIT 10.28 - PLURISTEM THERAPEUTICS INCexhibit_10-28.htm
EX-10.18 - EXHIBIT 10.18 - PLURISTEM THERAPEUTICS INCexhibit_10-18.htm
EX-31.2 - EXHIBIT 31.2 - PLURISTEM THERAPEUTICS INCexhibit_31-2.htm
EX-32.2 - EXHIBIT 32.2 - PLURISTEM THERAPEUTICS INCexhibit_32-2.htm
EX-10.21 - EXHIBIT 10.21 - PLURISTEM THERAPEUTICS INCexhibit_10-21.htm
EX-10.20 - EXHIBIT 10.20 - PLURISTEM THERAPEUTICS INCexhibit_10-20.htm
EX-10.24 - EXHIBIT 10.24 - PLURISTEM THERAPEUTICS INCexhibit_10-24.htm
EX-10.17 - EXHIBIT 10.17 - PLURISTEM THERAPEUTICS INCexhibit_10-17.htm
EX-10.30 - EXHIBIT 10.30 - PLURISTEM THERAPEUTICS INCexhibit_10-30.htm
EXCEL - IDEA: XBRL DOCUMENT - PLURISTEM THERAPEUTICS INCFinancial_Report.xls
10-K - 10-K - PLURISTEM THERAPEUTICS INCzk1415514.htm
EX-32.1 - EXHIBIT 32.1 - PLURISTEM THERAPEUTICS INCexhibit_32-1.htm
EX-10.22 - EXHIBIT 10.22 - PLURISTEM THERAPEUTICS INCexhibit_10-22.htm
Exhibit 23.1
 
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
 
We consent to the incorporation by reference in the Registration Statements on Form S-3 (Registration No. 333-171334, 333-170859, 333-151761, and 333-177009) and in the Registration Statements on Form S-8 (Registration No. 333-173777, 333-162577, 333-111591 and 333-196537) of Pluristem Therapeutics Inc. of our reports dated September 11, 2014, with respect to the consolidated financial statements of Pluristem Therapeutics Inc., and the effectiveness of internal control over financial reporting of Pluristem Therapeutics Inc., included in this Annual Report of Pluristem Therapeutics Inc. (Form 10-K) for the year ended June 30, 2014 filed with the Securities and Exchange Commission.
 
 
/s/ Kost Forer Gabbay & Kasierer
Kost Forer Gabbay & Kasierer
A member of Ernst & Young Global
 
Haifa, Israel
September 11, 2014
 
 

PLURISTEM THERAPEUTICS INC Reports